78 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
,
(unaudited)
December 31,
restated*
US$’000
Raw materials
Work in progress
Finished goods
Inventories
*See Note 16
Inventories for the period
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
debtors
VAT recoverable
Trade and other receivables
9. Inventories
As at
June 30, 2022(unaudited)
December 31, 2021(audited)
US$’000
Raw materials
Work
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
required to advance the manufacturing and characterization of our drug product and critical starting materials. We have a proven track record … to instruct the depositary to exercise the voting rights of the ordinary shares represented by ADSs. In lieu of distributing such materials, the depositary
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:58pm
methods required to advance the manufacturing and characterization of our drug product and critical starting materials. We have a proven track record … the depositary to exercise the voting rights of the ordinary shares represented by ADSs. In lieu of distributing such materials, the depositary bank
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:57pm
the manufacturing and characterization of our drug product and critical starting materials. We have a proven track record of obtaining rare disease … the depositary to exercise the voting rights of the ordinary shares represented by ADSs. In lieu of distributing such materials, the depositary bank may
F-3
0s8osc
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
cbbv5dvi lz
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
ptbnc77
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
EX-99.2
h3665gi0vkkofb7jb682
11 May 22
Current report (foreign)
4:30pm
424B3
9q8ab5rcn2i5e5ghk6s
4 May 22
Prospectus supplement
8:35am
424B3
p0ujfvlh4vsizdnzc
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
qsjex0g6 o572f5mcrp
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
ltm5v610yc5bqzqkp
9 Mar 22
Prospectus supplement
9:26am